Prognostic value of high-sensitivity cardiac troponin I in heart failure patients with mid-range and reduced ejection fraction.

Petr LokajJindrich SpinarLenka SpinarovaFilip MálekOndrej LudkaJan KrejciPetr OstadalDagmar VondrakovaKarel LabrMonika SpinarovaMonika Pavkova GoldbergovaMarie MiklikovaKaterina HelanovaIlona ParenicovaVladimir JakuboKlara BenesovaRoman MiklikJiri JarkovskyTomas OndrusJiri Parenica

Published in: PloS one (2021)

hs-cTnI levels ≥ 17 ng/l represent an independent increased risk of an adverse prognosis for patients with HFrEF and HFmrEF. Determining a patient's hs-cTnI level adds prognostic value to NT-proBNP and clinical parameters.

Keyphrases

case report
ejection fraction
emergency department
adverse drug